...
首页> 外文期刊>Medicinal chemistry research: an international journal for rapid communications on design and mechanisms of action of biologically active agents >Synthesis, molecular docking studies, and in vitro screening of sulfanilamide-thiourea hybrids as antimicrobial urease inhibitors
【24h】

Synthesis, molecular docking studies, and in vitro screening of sulfanilamide-thiourea hybrids as antimicrobial urease inhibitors

机译:磺胺-硫脲杂化物作为抗微生物脲酶抑制剂的合成,分子对接研究和体外筛选

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel hybrid molecules containing sulfanilamide and thiourea templates was designed and synthesized. These compounds were screened for antimicrobial and urease inhibitory activities. Some of the compounds revealed promising antibacterial and antifungal activities. Fascinatingly, the majority of the compounds exhibited potential urease inhibitory activities with IC50 ranging from 0.20 to 7.50 muM. Compound 2b was identified as the most potent urease inhibitor (IC50 0.20 muM), and was 100-fold more potent than thiourea, the standard inhibitor. Molecular docking studies of compounds were performed on 3D crystal structures of Jack bean and Helicobacter pylori ureases.
机译:设计并合成了一系列含有磺胺和硫脲模板的新型杂化分子。筛选了这些化合物的抗微生物和脲酶抑制活性。一些化合物显示出令人鼓舞的抗菌和抗真菌活性。令人着迷的是,大多数化合物显示出潜在的脲酶抑制活性,IC50为0.20至7.50μM。化合物2b被确定为最有效的脲酶抑制剂(IC50为0.20μM),并且比标准抑制剂硫脲的效力高100倍。化合物的分子对接研究是在Jack bean和幽门螺杆菌脲酶的3D晶体结构上进行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号